Respirogen

About:

Respirogen features a device technology provides oxygen independent from damaged lungs like Acute respiratory distress syndrome.

Website: https://respirogen.com/

Description:

Respirogen is a biotechnology company that features a device technology that provides oxygen-independent from damaged lungs like Acute respiratory distress syndrome. Its medical device is designed for several triggers, including pneumonia or trauma. The company was founded in 2017 and headquartered in Boulder, Colorado.

Total Funding Amount:

$500000

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Boulder, Colorado, United States

Founded Date:

2017-01-01

Founders:

Mark Borden

Number of Employees:

1-10

Last Funding Date:

2018-09-20

IPO Status:

Private

Industries:

© 2025 bioDAO.ai